logo
  

SouthGobi Resources Reports Further 30 Day Extension Of Delisting Review By TSX

SouthGobi Resources Ltd. reported confirmation of a further 30 day extension to the Toronto Stock Exchange delisting review.

A meeting of the Continued Listing Committee of TSX was scheduled to be held on July 27, and their decision was expected no later than July 29.

The company requested approval from the TSX for a 30 day extension of the delisting review hearing.

Subsequently, it received confirmation from the Continued Listing Committee of the TSX that it would defer its scheduled meeting to consider whether SouthGobi has met the listing requirements of the TSX until August 25.

The committee has determined to defer its delisting decision until no later than August 28.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT